Experts advocate holistic Semaglutide use as therapy goes off patent in India
They also differentiated the innovator biologic Semaglutide molecule from newer synthetic or chemical generic versions entering the market
They also differentiated the innovator biologic Semaglutide molecule from newer synthetic or chemical generic versions entering the market
Institute signs four MoUs, launches two products and marks 75 years with renewed focus on lab-to-market commercialisation
The study met its primary endpoint, showing a statistically significant and clinically meaningful improvement in progression-free survival
The patient, suffering from calcific severe aortic stenosis—a dangerous narrowing of the heart valve caused by calcium buildup—had run out of standard treatment options
The deal gives Cupid immediate access to Style Baazar’s fast-growing network of over 260 stores
The JADE trial enrolled 164 U.S. patients who initially received three monthly doses of OLN324 or faricimab, followed by 12 weeks off treatment with retreatment allowed only if disease recurred
Rs 66 lakh acquisition will support DNA engineering and novel cell-gene therapy alternatives to conventional chemotherapy
71-year-old high-risk patient with atrial fibrillation and ventricular tachycardia discharged next day
Hands-on clinical workshop in Bengaluru brings together neurologists, ENT specialists and physicians
Subscribe To Our Newsletter & Stay Updated